Interleukin 10 deficiency exacerbates toll-like receptor 3-induced preeclampsia-like symptoms in mice

Hypertension

Volumn 58, Issue 3, 2011, Pages 489-496

  Chatterjee, Piyali ^a   Chiasson, Valorie L ^a   Kopriva, Shelley E ^a   Young, Kristina J ^a   Chatterjee, Victor ^a   Jones, Kathleen A ^a   Mitchell, Brett M ^a  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

endothelium; hypertension; inflammation; Interleukin 10; preeclampsia; pregnancy; pregnancy induced

Indexed keywords

INTERLEUKIN 10; POLYINOSINIC POLYCYTIDYLIC ACID; RECOMBINANT INTERLEUKIN 10; TOLL LIKE RECEPTOR 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL REACTIVITY; CELL ACTIVATION; CELL ADHESION; CONTROLLED STUDY; DISEASE EXACERBATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FEMALE; FETUS; FETUS DEVELOPMENT; GENE SILENCING; HYPERTENSION; IMMUNOREGULATION; MALE; MOUSE; NONHUMAN; PLACENTA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN URINE LEVEL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE; VASODILATATION; WILD TYPE;

ANIMALS; ANTIGENS, CD31; AORTA; BLOOD PRESSURE; BLOTTING, WESTERN; CYTOKINES; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INTERLEUKIN-10; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLY I-C; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA; RECOMBINANT PROTEINS; TOLL-LIKE RECEPTOR 3; VASODILATION;

EID: 80051946919     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.172114     Document Type: Article

References (52)

1. Chang J, Elam-Evans LD, Berg CJ, Herndon J, Flowers L, Seed KA, Syverson CJ. Pregnancy-related mortality surveillance: United States, 1991-1998. MMWR Surveill Summ. 2003;52:1-8.
2. Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y. The role of the immune system in preeclampsia. Mol Aspects Med. 2007;28:192-209. (Pubitemid 46843191)
3. Visser N, van Rijn BB, Rijkers GT, Franx A, Bruinse HW. Inflammatory changes in preeclampsia: current understanding of the maternal innate and adaptive immune response. Obstet Gynecol Surv. 2007;62:191-201. (Pubitemid 46294788)
4. Borzychowski AM, Croy BA, Chan WL, Redman CW, Sargent IL. Changes in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cells. Eur J Immunol. 2005;35:3054-3063. (Pubitemid 41555101)
5. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Pre-eclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989;161:1200-1204.
6. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180: 499-506. (Pubitemid 29093892)
7. Hall DR. Is pre-eclampsia less common in patients with HIV/AIDS? J Reprod Immunol. 2007;76:75-77. (Pubitemid 350100883)
8. Dekker GA, Sibai BM. The immunology of preeclampsia. Semin Perinatol. 1999;23:24-33. (Pubitemid 29095583)
9. Bonney EA. Preeclampsia: a view through the danger model. J Reprod Immunol. 2007;76:68-74. (Pubitemid 350100873)
10. Koga K, Aldo PB, Mor G. Toll-like receptors and pregnancy trophoblast as modulators of the immune response. J Obstet Gynaecol Res. 2009;35: 191-202.
11. Riley JK, Nelson DM. Toll-like receptors in pregnancy disorders and placental dysfunction. Clin Rev Allergy Immunol. 2010;39:185-193.
12. Patni S, Wynen LP, Seager AL, Morgan G, White JO, Thornton CA. Expression and activity of Toll-like receptors 1-9 in the human term placenta and changes associated with labor at term. Biol Reprod. 2009; 80:243-248.
13. Gonzalez JM, Xu H, Ofori E, Elovitz MA. Toll-like receptors in the uterus, cervix, and placenta: is pregnancy an immunosuppressed state? Am J Obstet Gynecol. 2007;197:296.e1-e6.
14. van Rijn BB, Franx A, Steegers EA, de Groot CJ, Bertina RM, Pasterkamp G, Voorbij HA, Bruinse HW, Roest M. Maternal TLR4 and NOD2 gene variants, pro-inflammatory phenotype and susceptibility to early-onset preeclampsia and HELLP syndrome. PLoS One. 2008;3: e1865.
15. Xie F, Hu Y, Turvey SE, Magee LA, Brunham RM, Choi KC, Krajden M, Leung PC, Money DM, Patrick DM, Thomas E, von Dadelszen P. Toll-like receptors 2 and 4 and the cryopyrin inflammasome in normal pregnancy and pre-eclampsia. BJOG. 2010;117:99-108.
16. Kim YM, Romero R, Oh SY, Kim CJ, Kilburn BA, Armant DR, Nien JK, Gomez R, Mazor M, Saito S, Abrahams VM, Mor G. Toll-like receptor 4: a potential link between "danger signals," the innate immune system, and preeclampsia? Am J Obstet Gynecol. 2005;193:921-927.
17. Anand A, Gray ES, Brown T, Clewley JP, Cohen BJ. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med. 1987;316: 183-186. (Pubitemid 17052761)
18. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med. 1992;326:663-667.
19. Brown ZA, Selke S, Zeh J, Kopelman J, Maslow A, Ashley RL, Watts DH, Berry S, Herd M, Corey L. The acquisition of herpes simplex virus during pregnancy. N Engl J Med. 1997;337:509-515. (Pubitemid 27352016)
20. Tolfvenstam T, Papadogiannakis N, Norbeck O, Peterrson K, Broliden K. Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet. 2001;357:1494-1497. (Pubitemid 32488860)
21. Tinsley JH, Chiasson VL, Mahajan A, Young KJ, Mitchell BM. Toll-like receptor 3 activation during pregnancy elicits preeclampsia-like symptoms in rats. Am J Hypertens. 2009;22:1314-1319.
22. Azizieh F, Raghupathy R, Makhseed M. Maternal cytokine production patterns in women with preeclampsia. Am J Reprod Immunol. 2005;54: 30-37. (Pubitemid 40895147)
23. Jonsson Y, Ruber M, Matthiesen L, Berg G, Nieminen K, Sharma S. Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J Reprod Immunol. 2006;70:83-91.
24. Thaxton JE, Sharma S. Interleukin-10: a multi-faceted agent of pregnancy. Am J Reprod Immunol. 2010;63:482-491.
25. De Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med. 1991;174:915-924.
26. Willems F, Marchant A, Delville JP, Gerard C, Delvaux A, Velu T, de Boer M, Goldman M. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol. 1994;24:1007-1009. (Pubitemid 24093803)
27. Petit-Bertron AF, Pedron T, Gross U, Coppee JY, Sansonetti PJ, Cavaillon JM, Adib-Conquy M. Adherance modifies the regulation of gene expression induced by interleukin-10. Cytokine. 2005;29:1-12. (Pubitemid 39576697)
28. Molina-Holgado E, Arevalo-Martin A, Castrillo A, Bosca L, Vela JM, Guaza C. Interleukin-4 and interleukin-10 modulate nuclear factor kB activity and nitric oxide synthase-2 expression in Theiler's virus-infected brain astrocytes. J Neurochem. 2002;81:1242-1252. (Pubitemid 34809258)
29. Woodfin A, Voisin MB, Nourshargh S. PECAM-1: a multi-functional molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol. 2007;27:2514-2523. (Pubitemid 350158900)
30. Hennessy A, Pilmore HL, Simmons LA, Painter DM. A deficiency of placental IL 10 in preeclampsia. J Immunol. 1999;163:3491-3495.
31. White CA, Johansson M, Roberts CT, Ramsay AJ, Robertson SA. Effect of interleukin-10 null mutation on maternal immune response and reproductive outcome in mice. Biol Reprod. 2004;70:123-131. (Pubitemid 38063559)
32. Svensson L, Arvola M, Sallstrom MA, Holmdahl R, Mattsson R. The Th2 cytokines IL-4 and IL-10 are not crucial for the completion of allogeneic pregnancy in mice. J Reprod Immunol. 2001;51:3-7. (Pubitemid 32594861)
33. Smith SEP, Li J, Garbett K, Mirnics K, Patterson PH. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci. 2007;27:10695-10702. (Pubitemid 47535869)
34. Koga K, Cardenas I, Aldo P, Abrahams VM, Peng B, Fill S, Romero R, Mor G. Activation of TLR3 in the trophoblast is associated with preterm delivery. Am J Reprod Immunol. 2009;61:196-212.
35. Lin Y, Liang Z, Chen Y, Zeng Y. TLR3-involved modulation of pregnancy tolerance in double-stranded RNA-stimulated NOD/SCID mice. J Immunol. 2006;176:4147-4154. (Pubitemid 44264394)
36. Zhang J, Wei H, Wu D, Tian Z. Toll-like receptor 3 agonist induces impairment of uterine vascular remodeling and fetal losses in CBA X DBA/2 mice. J Reprod Immunol. 2007;74:61-67. (Pubitemid 46679061)
37. Tinsley JH, South S, Chiasson VL, Mitchell BM. Interleukin-10 reduces inflammation, endothelial dysfunction, and blood pressure in hyper-tensive pregnant rats. Am J Physiol Regul Integr Comp Physiol. 2010; 98:R713-R719.
38. Whitesall SE, Hoff JB, Vollmer AP, D'Alecy LG. Comparison of simultaneous measurement of mouse systolic arterial blood pressure by radiotelemetry and tail-cuff methods. Am J Physiol Heart Circ Physiol. 2004; 286:H2408-H2415. (Pubitemid 38685259)
39. Long C, Cook LG, Hamilton SL, Wu GY, Mitchell BM. FK506 binding protein 12/12.6 depletion increases endothelial nitric oxide synthase threonine 495 phosphorylation and blood pressure. Hypertension. 2007; 49:569-576.
40. Lortlar N, Kilic S, Bardakci Y, Budak G, Omeroglu S. Immunohistochemical evaluation of Pecam-1 (CD-31) and Icam-3 (CD-50) in preeclamptic placenta. Turkiye Klinikleri J Med Sci. 2009;29:1131-1136.
41. Zeisler H, Livingston JC, Schatten C, Tempfer C, Knofler M, Husslein P. Serum levels of adhesion molecules in women with pregnancy-induced hypertension. Wien Klin Wochenschr. 2001;113:588-592. (Pubitemid 33607963)
42. Sargent IL, Borzychowski AM, Redman CW. Immunoregulation in normal pregnancy and pre-eclampsia: an overview. Reprod Biomed Online. 2006;13:680-686. (Pubitemid 44760892)
43. LaMarca BD, Ryan MJ, Gilbert JS, Murphy SR, Granger JP. Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia. Curr Hypertens Rep. 2007;9:480-485.
44. Saito S, Sakai M. Th1/Th2 balance in preeclampsia. J Reprod Immunol. 2003;59:161-173. (Pubitemid 36945234)
45. Butz GM, Davisson RL. Long-term telemetric measurement of cardiovascular parameters in awake mice: a physiological genomics tool. Physiol Genomics. 2001;5:89-97. (Pubitemid 33675206)
46. Lai Z, Kalkunte S, Sharma S. A critical role of interleukin-10 in modulating hypoxia-induced preeclampsia-like disease in mice. Hypertension. 2011;57:505-514.
47. Renaud SJ, Cotechini T, Quirt JS, Macdonald-Goodfellow SK, Othman M, Graham CH. Spontaneous pregnancy loss mediated by abnormal maternal inflammation in rats is linked to deficient uteroplacental perfusion. J Immunol. 2011;186:1799-1808.
48. Zemse SM, Chiao CW, Hilgers RHP, Webb RC. Interleukin-10 inhibits the in vivo and in vitro adverse effects of TNF-on the endothelium of murine aorta. Am J Physiol Heart Circ Physiol. 2010;299:H1160-H1167.
49. Chaves MM, Silvestrini AA, Silva-Teixeira DN, Nogueira-Machado JA. Effect in vitro of interferon and interleukin-10 on generation of oxidizing species by human granulocytes. Inflamm Res. 1996;45:313-315. (Pubitemid 26245647)
50. Nonaka-Sarukawa M, Okada T, Ito T, Yamamoto K, Yoshioka T, Nomoto T, Hojo Y, Shimpo M, Urabe M, Mizukami H, Kume A, Ikeda U, Shimada K, Ozawa K. Adeno-associated virus vector-mediated systemic interleukin-10 expression ameliorates hypertensive organ damage in Dahl salt-sensitive rats. J Gene Med. 2008;10:368-374. (Pubitemid 351517092)
51. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683-765. (Pubitemid 32368050)
52. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy-review of a new approach. Pharmacol Rev. 2003;55:241-269.